SCHEMBL13425232

SCHEMBL13425232

O=c1[nH]c2nc3ccccc3n2c2nc(Cl)ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPA1 P27694 1/20 0.49
KDM4E B2RXH2 5/20 0.48
ALDH1A1 P00352 5/20 0.47
HPGD P15428 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
RAB9A P51151 5/20 0.45
NPC1 O15118 3/20 0.45
LMNA P02545 2/20 0.45
HSD17B10 Q99714 2/20 0.45
GAA P10253 2/20 0.45
TP53 P04637 1/20 0.45
MAPT P10636 1/20 0.45
PKM P14618 1/20 0.45
MAPK10 P53779 1/20 0.42
ADORA1 P30542 2/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
ADORA2A P29274 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13425234 0.84 KDM4E (0.53) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL30935867 0.78 RPA1 (0.57) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL15180301 0.78 RPA1 (0.57) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL6326045 0.75 KDM4E (0.43) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL5756993 0.75 RPA1 (0.48) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL21208437 0.74 ZAP70 (0.41) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL22045245 0.73 KDM4E (0.50) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL13425241 0.73 RPA1 (0.44) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL22045667 0.72 KDM4E (0.56) RPA1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL5753460 0.72 RPA1 (0.43) RPA1KDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100063046-A1 TETRACYCLIC IMIDAZOLE ANALOGS SENHWA BIOSCIENCES, INC. (TW) 2010-03-11 US disclosed
US-20100063046-A1 TETRACYCLIC IMIDAZOLE ANALOGS SENHWA BIOSCIENCES, INC. (TW) 2010-03-11 US disclosed
WO-2008060693-A2 TETRACYCLIC IMIDAZOLE ANALOGS CYLENE PHARMACEUTICALS, INC. (US) 2008-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063046-A1 TETRACYCLIC IMIDAZOLE ANALOGS BAD, API5, MCL1 RPA1 2674/4885KDM4E 1375/4885ALDH1A1 3035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.